U.S. Markets closed

PetMed Express Inc (PETS) Files 10-K for the Fiscal Year Ended on March 31, 2019

- By insider

PetMed Express Inc (PETS) files its latest 10-K with SEC for the fiscal year ended on March 31, 2019. PetMed Express Inc is a nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications and other health products for dogs, cats, and horses direct to the consumer. PetMed Express Inc has a market cap of $372.120 million; its shares were traded at around $18.00 with a P/E ratio of 9.77 and P/S ratio of 1.30. The dividend yield of PetMed Express Inc stocks is 5.99%. PetMed Express Inc had annual average EBITDA growth of 4.60% over the past ten years. GuruFocus rated PetMed Express Inc the business predictability rank of 1-star.

For the last quarter PetMed Express Inc reported a revenue of $64.6 million, compared with the revenue of $67.32 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $283.4 million, an increase of 3.5% from last year. For the last five years PetMed Express Inc had an average revenue growth rate of 4.6% a year.

The reported diluted earnings per share was $1.84 for the year, an increase of 1.1% from previous year. Over the last five years PetMed Express Inc had an EPS growth rate of 18.5% a year. The PetMed Express Inc had a decent operating margin of 16.29%, compared with the operating margin of 19.04% a year before. The 10-year historical median operating margin of PetMed Express Inc is 14.03%. The profitability rank of the company is 7 (out of 10).

At the end of the fiscal year, PetMed Express Inc has the cash and cash equivalents of $100.5 million, compared with $77.9 million in the previous year. The company had no long term debt. PetMed Express Inc has a financial strength rank of 10 (out of 10).

At the current stock price of $18.00, PetMed Express Inc is traded at 15.5% discount to its historical median P/S valuation band of $21.30. The P/S ratio of the stock is 1.30, while the historical median P/S ratio is 1.54. The intrinsic value of the stock is $20.72 a share, according to GuruFocus DCF Calculator. The stock lost 48.13% during the past 12 months.

For the complete 20-year historical financial data of PETS, click here.

This article first appeared on GuruFocus.